UPDATE 1-Pfizer loses UK patent case over use of Lyrica drug in pain
UPDATE 1-Pfizer loses UK patent case over use of Lyrica drug in pain
LONDON, Sept 10 (Reuters) - Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid.